Effect of Liraglutide on Weight Reduction in Euthyroid, Non Diabetic Obese Patients

Introduction: Liraglutide is an effective drug for the treatment of type 2 diabetes mellitus (T2DM). Liraglutide 3 mg is approved for obesity. We assessed the effect of liraglutide on body weight and tolerability in obese individuals with lesser dose. Objective: To evaluate the effect of the liraglutide on weight loss in overweight and obese Indian patients. Material and methods: Data was collected from 15 patients over 12 month duration from case record section retrospectively. Patient's weight and dose of liraglutide were studied. Result: Mean weight at baseline was 101.68 kg, minimum dose of liraglutide at the beginning was 0.3 mg .The mean change in body weight after 1 year was 13.39 kg and maximum dose of liraglutide was 2.4 mg. The most common side effect was nausea. Conclusion: Liraglutide treatment, at a much lower dose than 3 mg daily, significantly improves weight loss in obese non diabetic Indian subjects.